Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Beta-sitosterol is a naturally occurring **phytosterol** (plant sterol) with a structure similar to cholesterol and is widely distributed in fruits, vegetables, nuts, and seeds[3][6]. Chemically, it is known as stigmast-5-en-3β-ol, C29H50O, with a molecular weight of about 414.7 g/mol[1][6]. Beta-sitosterol is not a classical drug target such as a receptor, enzyme, or transporter, but rather a **bioactive plant molecule** with various pharmacological effects. It is used primarily for **lowering cholesterol**, **regulating prostate health (BPH)**, and has demonstrated potential **anticancer, anti-inflammatory, and immunomodulatory properties** in preclinical studies[1][3][5][7][9]. Mechanistically, it limits cholesterol absorption in the intestine, can arrest cancer cell growth by inducing cell cycle arrest and promoting apoptosis, and may regulate oxidative stress and immune responses[2][5][9]. While generally regarded as safe in foods, its role is more as a nutraceutical or dietary supplement and not as a direct molecular therapeutic target. Key notes: - **Beta-sitosterol is not a receptor, enzyme, transporter, or other canonical therapeutic target protein/molecule**. - It is frequently listed as an "active ingredient," not a drug target. - The field sometimes lists phytosterols as "targets," but here the correct categorization is as a **bioactive, non-target molecule**. - is_incorrect = true reflects that this is not a conventional therapeutic target such as a receptor or protein.
- Inhibits intestinal absorption of dietary cholesterol - Induces cell cycle arrest (often at G2/M phase) - Activates apoptotic pathways (e.g., caspase activation, increased Bax/Bcl-2 ratio) - Modulates oxidative stress and immune response pathways[2][5][9]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta-sitosterol.